Functional Assessment of Lesions: Advances with MRI

Computer tomography (CT) had taken over in the race to develop software capable of measuring FFR non-invasively. Magnetic resonance imaging (MRI) wouldn’t fall behind and has also tried non-inferiority vs an FFR based strategy, according to this study recently published in the prestigious NEJM, called MR-INFORM.

In patients with chronic angina and CAD risk factors, MR perfusion was associated to lower revascularization incidence, and also resulted non-inferior compared to FFR as regards major cardiac events.

All evidence (and guidelines alongside) points to ischemia driven revascularization. Anatomy lags making room to function, when it comes to deciding for or against revascularization. Obviously, once the decision has been made, tools such as IVUS or OCT are extremely useful for strategy planning. In fact, IVUS in particular has shown to reduce mortality when guiding PCI, and this is especially true for left main lesions.

The MR-INFORM randomized 918 patients with typical angina and at least two cardiovascular risk factors or a positive stress test to MR based strategy vs. FFR based strategy.


Read also: TCT 2018 | ULTIMATE: IVUS Guided DES Implantation for All Vessels, for All Lesions.


Revascularization was recommended for patients with at least 6% ischemia in MRI or in 0.8 or lower FFR.

Primary end point was a composite of death, non-fatal infarction or target vessel revascularization at one year. Non-inferiority cutoff value was a risk difference of 6%.

A total 184 over 454 (40.5%) in the MRI group and 213 of 464 in the FFR group (45.9%) met the criteria to recommend revascularization (p=0.11), though the MRI group saw fewer revascularizations (35.7% vs 45%; p=0.005).


Read also: The use of IVUS in unprotected left main PCI associated to better outcomes, compared to angiography guided PCI.


Primary end point occurred in 3.6% of patients in the MRI group vs. 3.7% in the FFR guided group; with these figures the MRI based strategy reached non-inferiority.

At one year, the percentage of patients free from angina resulted similar between the groups (49.2% in the MRI group vs 43.8% in the FFR).

Conclusion

In patients with chronic stable angina and CAE risk factors, myocardial perfusion cardiovascular MRI was associated with lower revascularization rate compared against the FFR based strategy and, in addition, MRI resulted non-inferior in major cardiovascular events.

Original Title: Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.

Reference: Eike Nagel et al. N Engl J Med 2019;380:2418-28.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...